摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(4-(trifluoromethyl)phenyl)quinazolin-4-amine | 849589-40-8

中文名称
——
中文别名
——
英文名称
N-(4-(trifluoromethyl)phenyl)quinazolin-4-amine
英文别名
N-[4-(trifluoromethyl)phenyl]quinazolin-4-amine
N-(4-(trifluoromethyl)phenyl)quinazolin-4-amine化学式
CAS
849589-40-8
化学式
C15H10F3N3
mdl
——
分子量
289.26
InChiKey
XPRLZMLSEYAJNL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.9
  • 重原子数:
    21
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    37.8
  • 氢给体数:
    1
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    N-(4-(trifluoromethyl)phenyl)quinazolin-4-amine二苯基乙炔四丁基溴化铵 、 copper diacetate 、 palladium diacetate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 12.0h, 以62%的产率得到4-(2,3-diphenyl-5-(trifluoromethyl)-1H-indol-1-yl)quinazoline
    参考文献:
    名称:
    Catalyst and solvent switched divergent C–H functionalization: oxidative annulation of N-aryl substituted quinazolin-4-amine with alkynes
    摘要:
    催化剂和溶剂控制的N-芳基取代的喹唑啉-4-胺与内部炔烃的C-H键的ortho/peri位选择性氧化环化。
    DOI:
    10.1039/d0ob00318b
  • 作为产物:
    描述:
    参考文献:
    名称:
    Catalyst and solvent switched divergent C–H functionalization: oxidative annulation of N-aryl substituted quinazolin-4-amine with alkynes
    摘要:
    催化剂和溶剂控制的N-芳基取代的喹唑啉-4-胺与内部炔烃的C-H键的ortho/peri位选择性氧化环化。
    DOI:
    10.1039/d0ob00318b
点击查看最新优质反应信息

文献信息

  • QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF HERPESVIRAL INFECTIONS
    申请人:GPC Biotech AG
    公开号:EP1673346A1
    公开(公告)日:2006-06-28
  • Quinazoline derivatives for the treatment of herpesviral infections
    申请人:Herget Thomas
    公开号:US20070123537A1
    公开(公告)日:2007-05-31
    The present invention relates to phenyl-quinazolinyl-amine derivatives and pharmaceutically acceptable salts thereof and pharmaceutical compositions comprising at least one of these derivatives and/or pharmaceutically salts thereof, as well as the use of these derivatives for the prophylaxis and/or treatment of herpesviral induced infections, including opportunistic infections, especially for the prophylaxis and/or treatment of infections and diseases induced by HCMV.
  • [EN] QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF HERPESVIRAL INFECTIONS<br/>[FR] DERIVES DE QUINAZOLINE POUR LE TRAITEMENT D'INFECTIONS VIRALES HERPETIQUES
    申请人:AXXIMA PHARMACEUTICALS AG
    公开号:WO2005040125A1
    公开(公告)日:2005-05-06
    The present invention relates to phenyl-quinazolinyl-amine derivatives and pharmaceutically acceptable salts thereof and pharmaceutical compositions comprising at least one of these derivatives and/or pharmaceutically salts thereof, as well as the use of these derivatives for the prophylaxis and/or treatment of herpesviral induced infections, including opportunistic infections, especially for the prophylaxis and/or treatment of infections and diseases induced by HCMV.
  • Catalyst and solvent switched divergent C–H functionalization: oxidative annulation of <i>N</i>-aryl substituted quinazolin-4-amine with alkynes
    作者:Siddi Ramulu Meesa、Praveen Kumar Naikawadi、Kishan Gugulothu、K. Shiva Kumar
    DOI:10.1039/d0ob00318b
    日期:——

    Catalyst and solvent controlled ortho/peri site-selective oxidative annulation of C–H bonds of N-aryl substituted quinazolin-4-amines with internal alkynes.

    催化剂和溶剂控制的N-芳基取代的喹唑啉-4-胺与内部炔烃的C-H键的ortho/peri位选择性氧化环化。
查看更多